NCCN Guidelines for Patients® | Chronic Myeloid Leukemia
6 NCCN Guidelines for Patients ® : Chronic Myeloid Leukemia, 2018 How to use this book Who should read this book? This book is about treatment for adults with chronic myeloid leukemia. This leukemia is called CML, for short. Patients and those who support them— caregivers, family, and friends—may find this book helpful. It is a good starting point to learn what your options may be. Are the book chapters in a certain order? Early chapters explain concepts that are repeated in later chapters. Part 1 explains what CML is. Knowing more about this leukemia may help you better understand its treatment. Parts 2 through 6 address issues related to treatment. Part 2 lists which health tests are needed before treatment. Part 3 briefly describes the main types of treatments so you can understand your options that are listed in Parts 4 and 5 . Tips for making treatment decisions are presented in Part 6 . Does this book include all options? This book includes information for many people. Your treatment team can point out what applies to you. They can also give you more information. While reading, make a list of questions to ask your doctors. The treatment options are based on science and the experience of NCCN experts. However, their recommendations may not be right for you. Your doctors may suggest other options based on your health and other factors. If other options are given, ask your treatment team questions. Help! What do the words mean? In this book, many medical words are included. These are words that your treatment team may say to you. Most of these words may be new to you. It may be a lot to learn. Don’t be discouraged as you read. Keep reading and review the information. Ask your treatment team to explain a word or phrase that you do not understand. Words that you may not know are defined in the text or in the Dictionary . Acronyms are also defined when first used and in the Glossary . Acronyms are short words formed from the first letters of several words. One example is DNA for d eoxyribo n ucleic a cid.